Skip to main content

Find Clinical Trials

Home
Conditions
Solid Tumor Malignancies, Cancer

Clinical trial condition

Solid Tumor Malignancies, Cancer

Explore clinical trials studying Solid Tumor Malignancies, Cancer. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Solid Tumor Malignancies, Cancer trial results

Recruiting

A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.

NCT06883539

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +31 more
Locations: China Medical University Hospital Taichung, Taiwan

National Cheng Kung University Hospital Tainan, Taiwan

View Trial Details

Not Yet Recruiting

A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors

NCT07185893

Conditions: Blood Platelet Disorders, CTIT-Chemotherapy Induced Thrombocytopenia, Cytopenia, +5 more
Locations: The Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China

View Trial Details

Completed

An Open-Label Study of E7974 Administered on Days 1, 8, and 15 of a 28-Day Cycle and Days 1 and 8 of a 21-Day Cycle in Patients With Solid Malignancies

NCT00121732

Conditions: Neoplasms, Solid Tumor Malignancies, Cancer
Locations: Indiana University Indianapolis, Indiana, United States

CTRC San Antonio, Texas, United States

View Trial Details